About CaRE2

The Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity Center is an NIH/National Cancer Institute collaborative partnership among University of Florida, Florida A&M University and University of Southern California (NIH/NCI 1U54CA233444). The diverse investigative team focuses on generating, translating and disseminating knowledge to reduce cancer disparities among bicoastal subpopulations of these groups. Through its rich research milieu, the Center trains underrepresented minority students and scientists while engaging with communities to better understand the needs of diverse populations and reduce cancer burdens. We look forward to partnering with you to minimize cancer disparities nationally and globally.

Specifically, the center focuses on studying relevant issues and serving the needs of:

(1) Black subpopulations, including American-born, African-born and Caribbean-born Blacks

(2) Latino subpopulations including Mexican-Americans, Caribbean Latinos, Central and South Americans


Our mission is to address cancer disparities in Black and Latino communities through high-impact and innovative research; to build research capacity and innovation; to train and educate underrepresented minority students and early stage investigators; to conduct culturally sensitive community engagement; and to prepare the next generation of scientists for cancer disparities research, from the molecule to the community to the clinic.


University of Florida
The UF CaRE2 Health Equity Center is based out of the UF Health Cancer Center and is led by Diana Wilkie, Ph.D., R.N., FAAN and Chengguo (Chris) Xing, Ph.D.

Diana Wilkie

Florida A&M University
The FAMU CaRE2 Health Equity Center is based out of the FAMU College of Pharmacy and is led by Renee Reams, Ph.D., and Kinfe Ken Redda, Ph.D.


University of Southern California
The USC CaRE2 Health Equity Center is based out the Keck School of Medicine USC and is led by John Carpten, Ph.D., and Mariana Stern, Ph.D.